![Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens: Molecular Therapy Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens: Molecular Therapy](https://www.cell.com/cms/attachment/9ee437f7-f0b6-4359-bcb1-6ec539ea800d/fx1_lrg.jpg)
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens: Molecular Therapy
![Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet](https://www.thelancet.com/cms/asset/1b910723-0066-4d56-b1fc-a26b052120ea/gr1.jpg)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet
![The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines - Cancer Treatment Reviews The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0edc6982-5b7f-42bc-9455-087eb9aab097/gr1_lrg.jpg)
The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines - Cancer Treatment Reviews
![Vaccines | Free Full-Text | An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives | HTML Vaccines | Free Full-Text | An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives | HTML](https://www.mdpi.com/vaccines/vaccines-10-00819/article_deploy/html/images/vaccines-10-00819-g001.png)
Vaccines | Free Full-Text | An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives | HTML
![Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance | Chemical Reviews Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance | Chemical Reviews](https://pubs.acs.org/cms/10.1021/acs.chemrev.2c00021/asset/images/medium/cr2c00021_0022.gif)
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance | Chemical Reviews
![Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/figures/mm7113a1-F-large.gif?_=49803)
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR
![Cancer vaccines as promising immuno-therapeutics: platforms and current progress | Journal of Hematology & Oncology | Full Text Cancer vaccines as promising immuno-therapeutics: platforms and current progress | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-022-01247-x/MediaObjects/13045_2022_1247_Fig3_HTML.png)
Cancer vaccines as promising immuno-therapeutics: platforms and current progress | Journal of Hematology & Oncology | Full Text
![Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy | SpringerLink Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12072-021-10285-5/MediaObjects/12072_2021_10285_Fig1_HTML.png)